Inferra AI / Company / CTVA
Corteva
CTVA · Materials
Last earnings Oct 1, 2026
Key results
EPSquarter
$1.74 billion
GAAP income and earnings per share (EPS) from continuing operations were $1.74 billion and $2.54 per share, respectively.
SEC original ↗Corteva — Earnings release (8-K exhibit)EX-99Nov 4, 2025
AI analysis
Q3 2025 · reported Nov 4, 2025
Based on: Earnings release + parent 8-K — transcript not held
Guidance · company-stated
Direction: Raised
“htm EX-99.1 a3q_2025xearningsxnewsxr 1 News Release Corteva Raises Full-Year Guidance on Strong Third Quarter and Year-To-Date 2025 Results YTD results reflect volume gains in both segments, demand for new technology, and outperformance on controllables Crop Protection YTD results driven by double-digit volume growth in new products and biologicals Seed YTD results reflect demand for newest hybrids and varieties, strong operational execution, and growth in out-licensing Full-year 2025 guidance3 raised due to year-to-date performance, incremental controllable lever benefits, and strength of growth platforms INDIANAPOLIS, Ind.”
Classified from the release's primary full-year outlook statement.
Capital allocation
Raw material deflation, productivity savings, and volume growth more than offset the unfavorable impact of currency, price pressure, and higher compensation and bad debt expense in SG&A.
The Company expects to repurchase approximately $1.0 billion of shares in 2025.
Event summary
3Q 2025 Results Overview Net Sales Loss from Cont
Based on: Earnings release + parent 8-K — transcript not held
Guidance & outlook
Direction: Raised
Company outlook: “htm EX-99.1 a3q_2025xearningsxnewsxr 1 News Release Corteva Raises Full-Year Guidance on Strong Third Quarter and Year-To-Date 2025 Results YTD results reflect volume gains in both segments, demand for new technology, and outperformance on controllables Crop Protection YTD results driven by double-digit volume growth in new products and biologicals Seed YTD results reflect demand for newest hybrids and varieties, strong operational execution, and growth in out-licensing Full-year 2025 guidance3 raised due to year-to-date performance, incremental controllable lever benefits, and strength of growth platforms INDIANAPOLIS, Ind.”
Company outlook — Raised (“Raises”)
“htm EX-99.1 a3q_2025xearningsxnewsxr 1 News Release Corteva Raises Full-Year Guidance on Strong Third Quarter and Year-To-Date 2025 Results YTD results reflect volume gains in both segments, demand for new technology, and outperformance on controllables Crop Protection YTD results driven by double-digit volume growth in new products and biologicals Seed YTD results reflect demand for newest hybrids and varieties, strong operational execution, and growth in out-licensing Full-year 2025 guidance3 raised due to year-to-date performance, incremental controllable lever benefits, and strength of growth platforms INDIANAPOLIS, Ind.”
Classified from the release's primary full-year outlook statement.
Capital allocation
Raw material deflation, productivity savings, and volume growth more than offset the unfavorable impact of currency, price pressure, and higher compensation and bad debt expense in SG&A.
SEC original ↗Corteva — Earnings release (8-K exhibit)EX-99Nov 4, 2025
The Company expects to repurchase approximately $1.0 billion of shares in 2025.
SEC original ↗Corteva — Earnings release (8-K exhibit)EX-99Nov 4, 2025
Strategy & priorities
Price/Mix was up 3% led by North America2 and EMEA2 with continued execution on the Company s price-for-value strategy for new technology offerings.
SEC original ↗Corteva — Earnings release (8-K exhibit)EX-99Nov 4, 2025
In Crop Protection, demand for differentiated technology and productivity gains support margin expansion, while Seed continues to benefit from its strength in advanced genetics, growth in out-licensing and ongoing cost discipline.
SEC original ↗Corteva — Earnings release (8-K exhibit)EX-99Nov 4, 2025
Our planned separation in the second half of 2026 is driven by our belief that it will create long-term value, as New Corteva and SpinCo strengthen their positions as market leaders with sharper focus, tailored capital allocation strategies and increased flexibility.
SEC original ↗Corteva — Earnings release (8-K exhibit)EX-99Nov 4, 2025
Chuck Magro Chief Executive Officer Company Updates On October 1, 2025, the Company announced its plan to separate into two independent public companies: New Corteva, focused on differentiated technology solutions in crop protection, including biologicals, and SpinCo, dedicated to advanced genetics and emerging technologies including gene editing, hybrid wheat, and biofuels.
SEC original ↗Corteva — Earnings release (8-K exhibit)EX-99Nov 4, 2025
Strategic Rationale Distinct Market Opportunities: The separation enables tailored innovation, operational design, and go-to-market strategies for each company.
SEC original ↗Corteva — Earnings release (8-K exhibit)EX-99Nov 4, 2025
Risks & headwinds
As it pertains to ongoing tariff negotiations around the world, we are not expecting a material net impact on our full-year 2025 results given policies in place today.
SEC original ↗Corteva — Earnings release (8-K exhibit)EX-99Nov 4, 2025
(NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world s most pressing agriculture challenges.
SEC original ↗Corteva — Earnings release (8-K exhibit)EX-99Nov 4, 2025
All statements that address expectations or projections about the future, including statements about Corteva s financial results or outlook; strategy for growth; product development; regulatory approvals; market position; capital allocation strategy; liquidity; sustainability targets and initiatives; the anticipated benefits of acquisitions, restructuring actions, or cost savings initiatives; and the outcome of contingencies, such as litigation and environmental matters, are forward-looking statements.
SEC original ↗Corteva — Earnings release (8-K exhibit)EX-99Nov 4, 2025
Forward-looking statements and other estimates also involve risks and uncertainties, many of which are beyond the company's control.
SEC original ↗Corteva — Earnings release (8-K exhibit)EX-99Nov 4, 2025
While the list of factors presented below is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties.
SEC original ↗Corteva — Earnings release (8-K exhibit)EX-99Nov 4, 2025
Additionally, there may be other risks and uncertainties that Corteva is unable to currently identify or that Corteva does not currently expect to have a material impact on its business.
SEC original ↗Corteva — Earnings release (8-K exhibit)EX-99Nov 4, 2025
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
70 documents- Q3 2026
- 8-KCTVA
Oct 13, 2026
- 8-KCTVA
Oct 7, 2026
- 8-KCTVA
Oct 7, 2026
- 8-KCTVA
Oct 5, 2026
- 8-KCTVA
Oct 1, 2026
- 8-KCTVA
Oct 1, 2026
- 8-KCTVA
Oct 1, 2026
- 8-KCTVA
Oct 1, 2026
- Q2 2026
- 8-KCTVA
Sep 30, 2026
- 8-KCTVA
Sep 25, 2026
- EX-99CTVA
Sep 25, 2026
- 8-KCTVA
Sep 24, 2026
- EX-99CTVA
Sep 24, 2026
- 8-KCTVA
Sep 21, 2026
- 8-KCTVA
Sep 15, 2026
- EX-99CTVA
Sep 15, 2026
- 8-KCTVA
Sep 10, 2026
- 8-KCTVA
Aug 31, 2026
- EX-99CTVA
Aug 31, 2026
- 8-KCTVA
Aug 20, 2026
- 8-KCTVA
Aug 20, 2026
- EX-99CTVA
Aug 20, 2026
- 8-KCTVA
Aug 14, 2026
- 8-KCTVA
Aug 6, 2026
- EX-99CTVA
Aug 6, 2026
- 10-QCTVA
Jul 31, 2026
- 8-KCTVA
Jul 30, 2026
- Q1 2026
- 8-KCTVA
Jun 29, 2026
- EX-99CTVA
Jun 29, 2026
- EX-99CTVA
Jun 29, 2026
- 8-K/ACTVA
Jun 12, 2026
- 10-QCTVA
May 6, 2026
- 8-KCTVA
May 5, 2026
- 8-KCTVA
May 1, 2026
- 8-KCTVA
Apr 14, 2026
- Q4 2025
- 10-KCTVA
Feb 12, 2026
- 8-KCTVA
Feb 3, 2026
- Q3 2025
- 10-QCTVA
Nov 5, 2025
- 8-KCTVA
Nov 4, 2025
- 8-KCTVA
Oct 1, 2025
- EX-99CTVA
Oct 1, 2025
- Q2 2025
- 8-KCTVA
Aug 26, 2025
- 10-QCTVA
Aug 7, 2025
- 8-KCTVA
Aug 6, 2025
- Q1 2025
- 10-QCTVA
May 8, 2025
- 8-KCTVA
May 7, 2025
- 8-KCTVA
May 6, 2025
- Q4 2024
- 8-KCTVA
Feb 19, 2025
- 10-KCTVA
Feb 14, 2025
- 8-KCTVA
Feb 5, 2025
- Q3 2024
- 10-QCTVA
Nov 7, 2024
- 8-KCTVA
Nov 6, 2024
- 8-KCTVA
Oct 15, 2024
- Q2 2024
- 10-QCTVA
Aug 1, 2024
- 8-KCTVA
Jul 31, 2024
- EX-99CTVA
Jul 31, 2024
- Q1 2024
- 8-KCTVA
May 2, 2024
- 10-QCTVA
May 2, 2024
- 8-KCTVA
May 1, 2024
- Q4 2023
- 10-KCTVA
Feb 8, 2024
- 8-KCTVA
Jan 31, 2024
- Q3 2023
- 10-QCTVA
Nov 9, 2023
- 8-KCTVA
Nov 8, 2023
- 8-KCTVA
Oct 27, 2023
- Q2 2023
- 10-QCTVA
Aug 4, 2023
- 8-KCTVA
Aug 3, 2023
- Q1 2023
- 8-KCTVA
May 15, 2023
- 10-QCTVA
May 4, 2023
- 8-KCTVA
May 3, 2023
- 8-KCTVA
Apr 27, 2023
Earnings releases
40 documents- Q3 2026
- EX-99CTVA
Oct 1, 2026
- EX-99CTVA
Oct 1, 2026
- EX-99CTVA
Oct 1, 2026
- EX-99CTVA
Oct 1, 2026
- EX-99CTVA
Oct 1, 2026
- Q2 2026
- EX-99CTVA
Sep 30, 2026
- EX-99CTVA
Aug 6, 2026
- EX-99CTVA
Jul 30, 2026
- EX-99CTVA
Jul 30, 2026
- Q1 2026
- EX-99CTVA
May 5, 2026
- EX-99CTVA
May 5, 2026
- EX-99CTVA
Apr 14, 2026
- EX-99CTVA
Apr 14, 2026
- EX-99CTVA
Apr 14, 2026
- Q4 2025
- EX-99CTVA
Feb 3, 2026
- EX-99CTVA
Feb 3, 2026
- Q3 2025
- EX-99CTVA
Nov 4, 2025
- EX-99CTVA
Nov 4, 2025
- Q2 2025
- EX-99CTVA
Aug 6, 2025
- EX-99CTVA
Aug 6, 2025
- Q1 2025
- EX-99CTVA
May 7, 2025
- EX-99CTVA
May 7, 2025
- Q4 2024
- EX-99CTVA
Feb 5, 2025
- EX-99CTVA
Feb 5, 2025
- Q3 2024
- EX-99CTVA
Nov 6, 2024
- EX-99CTVA
Nov 6, 2024
- Q2 2024
- EX-99CTVA
Jul 31, 2024
- EX-99CTVA
Jul 31, 2024
- Q1 2024
- EX-99CTVA
May 1, 2024
- EX-99CTVA
May 1, 2024
- Q4 2023
- EX-99CTVA
Jan 31, 2024
- EX-99CTVA
Jan 31, 2024
- Q3 2023
- EX-99CTVA
Nov 8, 2023
- EX-99CTVA
Nov 8, 2023
- EX-99CTVA
Oct 27, 2023
- EX-99CTVA
Oct 27, 2023
- Q2 2023
- EX-99CTVA
Aug 3, 2023
- EX-99CTVA
Aug 3, 2023
- Q1 2023
- EX-99CTVA
May 3, 2023
- EX-99CTVA
May 3, 2023
Presentations
0 documentsNo presentations for Corteva are held in this edition of the library.
Transcripts
0 documentsNo transcripts for Corteva are held in this edition of the library.
Mentioned by
8 companiesOther tracked companies whose held documents mention Corteva by name or ticker. A mention is counted once per document, from the document text the library holds.
“erest income for New EIDP; and standalone EIDP, Inc. dividends declared to the standalone Corteva, Inc. subsidiary not yet paid (refer to New EIDP Note 1 - Basis… …and Basis of Presentation 11 2 Summary of Significant Accounting Policies 12 3 Rec”
“ interest income for New EIDP; standalone EIDP, Inc. dividends declared to the standalone Corteva, Inc. subsidiary not yet paid; and the capital structure of New… …Table of Contents Note Page 1 Summary of Significant Accounting Policies 9 2 Rec”
“mmon stock from continuing operations $ 0.24 (p) Diluted earnings… …spun off from Corteva. The Crop Protection Business is a component of Corteva that has operations and cash flows that are clearly distinguished for operational and financial ”
“hare of common stock from continuing operations $ 2.89 … …purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date (“2024 Share Buyback Plan”). The timing, price and volume of purchases will ”
“itigation relating to the separation, as well as the risks and uncertainties described in Corteva’s and Vylor’s…”
“…DuPont, Chemours and Corteva Reach Agreement to Resolve PFAS-Related Claims in North Carolina • Resolves litigations brought by the State of North Carolina and 11 local entities rel”
Allison Transmission Holdings Inc. (ALSN)
“ that … …attributable to noncontrolling interests 3 4 Net income (loss) attributable to Corteva $ 720 $ 652 Basic earnings (loss) per share of common stock: Basic earnings (loss) per share of common stock from continuing… …NOTES TO THE INTERIM ”
“…Chemours, DuPont and Corteva Reach Agreement to Resolve PFAS-Related Claims in North Carolina • Resolves litigations brought by the State of North Carolina and 11 local entities rel”
See also the earnings calendar for every tracked company’s next earnings date.